benextramine has been researched along with Leukemia, Erythroblastic, Acute in 1 studies
benextramine: RN given refers to parent cpd
Leukemia, Erythroblastic, Acute: A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McKernan, RM | 1 |
| Strickland, WR | 1 |
| Insel, PA | 1 |
1 other study available for benextramine and Leukemia, Erythroblastic, Acute
| Article | Year |
|---|---|
Selective blockade and recovery of cell surface alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells. Studies with the irreversible antagonist benextramine.
Topics: Binding, Competitive; Cell Compartmentation; Cell Membrane; Cyclic AMP; Cystamine; Humans; Kinetics; | 1988 |